| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 07/13/2005 | CN1639144A Method for purifying tetrahydrofuran by distillation |
| 07/13/2005 | CN1639135A N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials |
| 07/13/2005 | CN1639130A Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/13/2005 | CN1639128A O-cyclopropyl-carboxanilides and their use as fungicides |
| 07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
| 07/13/2005 | CN1639118A Method for the simultaneous production of tetrahydrofurans and pyrrolidones |
| 07/13/2005 | CN1638763A Antidepressant |
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636967A Noval compounds, their use and preparation |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1636559A Ethers of o-desmethyl venlafaxine |
| 07/13/2005 | CN1636457A Fungicides for the control of take-all disease of plants |
| 07/13/2005 | CN1210271C Improved method for producing unsaturated cyclic ethers |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/13/2005 | CN1210248C Process for prepn. of cyclopropane formic ether |
| 07/13/2005 | CN1210025C Tanshinone compound containing dihydrofuran ring structure for curing hyperammonemia and hepatic encephalopathy |
| 07/13/2005 | CN1210024C Crytotanshinone for preventing and delaying early senile dementia |
| 07/12/2005 | US6916959 Halogen-containing aromatic compound |
| 07/12/2005 | US6916956 Calcium receptor antagonist |
| 07/12/2005 | US6916941 Crystallization fromn solutions; antidepressant |
| 07/12/2005 | US6916936 Comprises carbene precursor; by-product inhibition; for chemical waste disposal, plastics recycling; pollution control |
| 07/12/2005 | US6916835 Nitrate esters and their use for neurological conditions |
| 07/12/2005 | US6916812 Dietetic agents |
| 07/12/2005 | US6916797 α-arylethylpiperazine derivatives as neurokinin antagonists |
| 07/12/2005 | CA2238859C Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | WO2005061476A2 Aroylfuranes and aroylthiophenes |
| 07/07/2005 | WO2005061475A2 Ornithine derivatives as prostaglandin e2 agonists or antagonists |
| 07/07/2005 | WO2005061464A1 Herbicidal heteroaroyl-substituted phenylalanine amides |
| 07/07/2005 | WO2005061459A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | WO2005061450A2 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | WO2005060456A2 Method for treating adamts-5-associate disease |
| 07/07/2005 | WO2005049593A3 N-acylsulfonamide apoptosis promoters |
| 07/07/2005 | WO2005037810A3 Cyclopropyl methanone derivatives, the preparation and the therapeutic use thereof |
| 07/07/2005 | US20050148796 Compounds and methods for preparing methanesulfonamides |
| 07/07/2005 | US20050148783 Nonexplosive intermediates for preparation of fluoropolymers; environmentally friendly; including stable, high yield hypofluorite reactive molecules |
| 07/07/2005 | US20050148782 Gas phase oxidation of xylene and/or naphthalene in a shell-and-tube reactor thermostatted by means of a heat transfer medium over three or more different fixed-bed catalysts arranged in zones such that the maximum temperature in the second and third zones are lower than in the first; high yields |
| 07/07/2005 | US20050148660 Novel retinol derivative and cosmetic composition comprising the same |
| 07/07/2005 | US20050148650 protein kinase B activating agents for preventing or treating depression, PTSD, Parkinson's disease, Alzheimer's diseases, and the like; comprises for e.g. [1] 2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]isoindoline |
| 07/07/2005 | US20050148648 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators |
| 07/07/2005 | US20050148646 Dicationic triaryl analogs as anti-protozoan agents |
| 07/07/2005 | US20050148644 Ligands for Inosine-5'-monophosphate dehydrogenase; antiviral, antiinflammatory, antibiotics, transplant rejection, autoimmune disease, , antipsoriatic immunosuppressants; 3-uriedo benzyl carbamate derivatives; high potency, side effects reduction; bioavailability; antivascular hyperproliferative |
| 07/07/2005 | US20050148623 HIV protease inhibiting compounds |
| 07/07/2005 | US20050148613 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/07/2005 | US20050148599 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 07/07/2005 | US20050148595 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 07/07/2005 | US20050148590 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
| 07/07/2005 | US20050148588 LFA-1 antagonist compounds |
| 07/07/2005 | US20050148584 N-(3-(2-(4-morpholino)ethyloxy)phenyl)-N-{(cis3-(benzylamino)cyclohexyl)methyl}-N'-phenylurea; useful for the treatment of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 07/07/2005 | US20050148577 2-methyl-1,8-dioxa-dibenzo[e,h]azulene; potentiation; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 07/07/2005 | US20050148550 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 07/07/2005 | US20050148548 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
| 07/07/2005 | US20050148517 Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
| 07/07/2005 | US20050147897 Ultraviolet transmitting fluoropolymer and pellicle comprising said polymer |
| 07/07/2005 | US20050147674 A tablet or capsule prepared from a mixture of crystalline escitalopram oxalate having a median particle size of > 40 mu m and excipients; large particle size for use in direct compression; controlled crystallization from solution to avoid granulation and drying steps; binder-and lactose-free |
| 07/07/2005 | CA2792483A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2550958A1 Ornithine derivatives as prostaglandin e2 agonists or antagonists |
| 07/07/2005 | CA2549389A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | CA2548513A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | CA2548354A1 Herbicidal heteroaroyl-substituted phenylalanine amides |
| 07/07/2005 | CA2547575A1 Method for treating adamts-5-associated disease |
| 07/06/2005 | EP1550655A1 Bicyclic intermediates |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP1549598A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif) |
| 07/06/2005 | EP1549306A1 Substituted phenylsulfonamide inhibitors of beta amyloid production |
| 07/06/2005 | EP1446397B1 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| 07/06/2005 | EP1233961B1 Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination |
| 07/06/2005 | CN1636003A Vitamin D3 derivatives and remedies using the same |
| 07/06/2005 | CN1635989A Preparation of phthalic anhydride |
| 07/06/2005 | CN1634907A Process for stirring type multi-kettle continuous oxidation preparation of trimellitic anhydride |
| 07/06/2005 | CN1634906A Synthesis of 5-bromo phthalide |
| 07/06/2005 | CN1634905A Use of Lignans compound used for anti-osteoporosis medicine |
| 07/06/2005 | CN1634904A Process for synthesis of aryl bis-ether dianhydrides monomer |
| 07/06/2005 | CN1634903A Method for preparing furfural from acidified filtrate of pulping black liquid |
| 07/06/2005 | CN1209356C Method for splitting antipode of 3-butylbenzene phthalein |
| 07/06/2005 | CN1209355C Derivate of sweetsop lactone as well as preparation method and usage |
| 07/05/2005 | CA2151377C Aminomethylindans, -benzofurans and -benzothiophenes |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058858A1 Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder |
| 06/30/2005 | WO2005058857A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 06/30/2005 | WO2005058856A1 A process for the liquefaction of lignocellulosic material |
| 06/30/2005 | WO2005058855A1 Process for the production of ethers |
| 06/30/2005 | WO2005058854A1 Norbornane lactone (meth)acrylate and polymer thereof |
| 06/30/2005 | WO2005058853A2 Method for the production of defined mixtures of thf, bdo and gbl by gas phase hydrogenation |
| 06/30/2005 | WO2005058812A2 Prostaglandin synthesis |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058492A1 Improved catalyst for hydrogenating maleic anhydride to form y-butyrolactone and tetrahydrofuran |
| 06/30/2005 | WO2005058491A1 Catalyst extrudates based on copper oxide and their use for hydrogenating carbonyl compounds |
| 06/30/2005 | WO2005034878A3 Pyrovalerone analogs and therapeutic uses thereof |
| 06/30/2005 | WO2005026141A8 Process for preparation of substituted butenolides via palladium-free etherification and amination of masked mucohalic acids |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | WO2005016277A3 Arylsulfonamidobenzylic compounds |
| 06/30/2005 | WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 06/30/2005 | US20050143579 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 06/30/2005 | US20050143475 Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
| 06/30/2005 | US20050143453 Selective preventing and therapeutic agents for progressive lesion after organic damage |